| 036a | XA-DE |
| 037b | eng |
| 077a | 310266068 Buchausg. u.d.T.: ‡Müller-Langer, Frank, 1978 - : Creating R&D incentives for medicines for neglected diseases |
| 087q | 978-3-8349-1730-0 |
| 100 | Müller-Langer, Frank |
| 331 | Creating R&D Incentives for Medicines for Neglected Diseases |
| 335 | An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research |
| 410 | Wiesbaden |
| 412 | Gabler Verlag / GWV Fachverlage GmbH, Wiesbaden |
| 425 | 2009 |
| 425a | 2009 |
| 433 | Online-Ressource (XIX, 297p. 8 illus, digital) |
| 451b | SpringerLink. Bücher |
| 501 | Includes bibliographical references and index |
| 517 | Preliminary; Introduction; The TRIPS Agreement and Access to Patented Medicines; Economic Analysis of Patents; Patent Protection in the Developing World: Theory and Evidence; Legal and Economic Analysis of Parallel Imports; Solutions for the Problem of Underinvestment in R&D for Medicines for Neglected Infectious and Tropical Diseases; Conclusion and Ideas for Further Research; Back matter |
| 527 | Buchausg. u.d.T.: ‡Müller-Langer, Frank, 1978 - : Creating R&D incentives for medicines for neglected diseases |
| 540a | ISBN 978-3-8349-8323-7 |
| 540a | ISBN 978-3-8349-1730-0 |
| 700 | |KJMV6 |
| 700 | |PDG |
| 700 | |BUS087000 |
| 700b | |658.514 |
| 700b | |615.321 |
| 700c | |HD28-70 |
| 700g | 1271420821 PR 2352 |
| 700g | 1271486539 QX 840 |
| 700g | 1270876899 QR 525 |
| 700g | 127074268X QC 344 |
| 750 | This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical diseases, such as malaria or leishmaniasis, are among the main causes of death and disability in developing countries. Medical scholars have since long argued that medicines for those neglected infectious diseases either do not exist at all or badly need improvement. This neglect has two main reasons. First |
| 902s | 209066393 Pharmazeutische Industrie |
| 902s | 208921532 Forschung und Entwicklung |
| 902s | 209596244 Tropenkrankheit |
| 902s | 209481471 Investitionsverhalten |
| 902s | 209646683 Anreiz |
| 907s | 209066393 Pharmazeutische Industrie |
| 907s | 208921532 Forschung und Entwicklung |
| 907s | 209596244 Tropenkrankheit |
| 907s | 209481471 Investitionsverhalten |
| 907s | 209646683 Anreiz |
| 012 | 313878374 |
| 081 | Müller-Langer, Frank: Creating R&D Incentives for Medicines for Neglected Diseases |
| 100 | Springer E-Book |
| 125a | Elektronischer Volltext - Campuslizenz |
| 655e | $uhttp://dx.doi.org/10.1007/978-3-8349-8323-7 |
